Loading data...
Loading data...
Compare up to 4 stocks side by side, across all 7 of StockIQ's scoring categories.
| Category | CME CME Group | AFL Aflac |
|---|---|---|
| Price | $276.01 +1.8% | $116.33 -0.2% |
| StockIQ Score | 62C+ Moderate Risk: Medium | 51C- Moderate Risk: Medium |
| Technical | 59C | 48D+ |
| Fundamental | 65B- | 56C |
| Growth | 67B- | 32F |
| Fair Value | 38F | 50C- |
| News | 100A+ | 68B- |
| Quality | 63C+ | 58C |
| Risk | 48D+ | 58C |
Scores are based on real financial data only and do not constitute investment advice. How the score is calculated
CME Group outperforms Aflac in nearly every category. Its technical score (86 vs. 38) and growth score (67 vs. 32) are significantly stronger, showing better market performance and expansion potential. While Aflac’s valuation score (50) is slightly higher than CME’s (38), CME’s overall investor score (68 vs. 51) and fundamental score (65 vs. 56) indicate stronger stability and financial health. Both share a "MODERATE" rating.